{"transactions":[{"id":2222083,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:47:04.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":65000,"derivative":{"exercise_price":2.12,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001689548-22-000091","document":"wf-form4_165610361036996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954822000091/wf-form4_165610361036996.xml","form_type":"4"}},{"id":2394568,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-16T00:38:24.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":3057,"price":12.85,"value":39282.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":99476,"source":{"system":"sec-edgar","filing":"0001689548-22-000007","document":"wf-form4_164497188813645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954822000007/wf-form4_164497188813645.xml","form_type":"4"}},{"id":2437778,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T21:08:40.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":77000,"derivative":{"exercise_price":18.11,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001104659-22-003162","document":"tm222494-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465922003162/tm222494-4_4seq1.xml","form_type":"4"}},{"id":2437777,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-11T21:08:40.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Ravina was awarded 22,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":102533,"source":{"system":"sec-edgar","filing":"0001104659-22-003162","document":"tm222494-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465922003162/tm222494-4_4seq1.xml","form_type":"4"}},{"id":2854891,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T21:55:25.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":65800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 75% vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date."}],"balance_after":65800,"derivative":{"exercise_price":52.53,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":65800},"source":{"system":"sec-edgar","filing":"0001689548-21-000009","document":"wf-form4_161359890175184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954821000009/wf-form4_161359890175184.xml","form_type":"4"}},{"id":2854890,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-17T21:55:25.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":24512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Ravina was awarded 24,512 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest over a four-year period, with 10,412 shares vesting on February 12, 2022, 4,700 shares vesting on February 12, 2023, 4,700 shares vesting on February 12, 2024 and 4,700 shares vesting on February 12, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":80533,"source":{"system":"sec-edgar","filing":"0001689548-21-000009","document":"wf-form4_161359890175184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954821000009/wf-form4_161359890175184.xml","form_type":"4"}},{"id":2920755,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T00:13:24.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":45000,"price":2.27,"value":102150.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vested and became exercisable on August 21, 2019, with the remainder vesting in 36 equal monthly installments thereafter. This option was initially for 195,500 shares and the Reporting Person has exercised his option to purchase 56,021 shares since such grant date."}],"balance_after":139479,"derivative":{"exercise_price":2.27,"expiration_date":"2028-10-18","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-21-000107","document":"wf-form4_160989198758164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000162828021000107/wf-form4_160989198758164.xml","form_type":"4"}},{"id":2920754,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-06T00:13:24.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":45000,"price":2.27,"value":102150.0,"ownership":{"direct":true},"balance_after":56021,"source":{"system":"sec-edgar","filing":"0001628280-21-000107","document":"wf-form4_160989198758164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000162828021000107/wf-form4_160989198758164.xml","form_type":"4"}},{"id":3964778,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-12T20:01:23.000Z","date":"2018-04-10","kind":"sale","acquired":false,"shares":2451,"price":18.38,"value":45049.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.04 to $18.61, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-023708","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918023708/a4.xml","form_type":"4"}},{"id":3996384,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-14T20:07:28.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":2451,"price":25.16,"value":61667.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":2451,"source":{"system":"sec-edgar","filing":"0001104659-18-017480","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918017480/a4.xml","form_type":"4"}},{"id":4003445,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-10T00:11:49.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan.  The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date.  The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of the Vesting Commencement Date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":65000,"derivative":{"exercise_price":28.72,"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001104659-18-016414","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918016414/a4.xml","form_type":"4"}},{"id":4062927,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-13T21:10:49.000Z","date":"2018-02-12","kind":"sale","acquired":false,"shares":2451,"price":18.24,"value":44706.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":4902,"source":{"system":"sec-edgar","filing":"0001104659-18-009011","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918009011/a4.xml","form_type":"4"}},{"id":4100531,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-12T13:57:33.000Z","date":"2018-01-10","kind":"sale","acquired":false,"shares":3630,"price":16.4,"value":59532.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":7353,"source":{"system":"sec-edgar","filing":"0001104659-18-001967","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918001967/a4.xml","form_type":"4"}},{"id":4133391,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-13T21:02:19.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":5490,"price":13.63,"value":74828.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.32 to $14.03, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":10983,"source":{"system":"sec-edgar","filing":"0001104659-17-073124","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465917073124/a4.xml","form_type":"4"}},{"id":4165703,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-11-13T21:15:06.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":5490,"price":13.26,"value":72797.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.50, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":16473,"source":{"system":"sec-edgar","filing":"0001104659-17-067963","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465917067963/a4.xml","form_type":"4"}},{"id":4187462,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-12T23:28:42.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":10980,"price":20.33,"value":223223.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.93 to $20.49, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":21963,"source":{"system":"sec-edgar","filing":"0001104659-17-062001","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465917062001/a4.xml","form_type":"4"}},{"id":4210438,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-13T21:23:07.000Z","date":"2017-09-11","kind":"sale","acquired":false,"shares":10980,"price":14.3,"value":157014.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.95, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This total reflects an adjustment for a clerical error on the reporting person's Form 3 wherein the number of shares beneficially owned was inadvertently overstated by 62,744 shares.  Such shares were sold prior to Dr. Ravina becoming a reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This total reflects the number of shares beneficially owned by the reporting person as of the date hereof, following the reported transaction and inclusive of all intervening transactions."}],"balance_after":32943,"source":{"system":"sec-edgar","filing":"0001104659-17-056988","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465917056988/a4.xml","form_type":"4"}},{"id":4210437,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-13T21:23:07.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":5490,"price":10,"value":54900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This total reflects the number of shares beneficially owned by the reporting person on July 20, 2017, following the reported transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This total reflects an adjustment for a clerical error on the reporting person's Form 3 wherein the number of shares beneficially owned was inadvertently overstated by 62,744 shares.  Such shares were sold prior to Dr. Ravina becoming a reporting person."}],"balance_after":49413,"source":{"system":"sec-edgar","filing":"0001104659-17-056988","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465917056988/a4.xml","form_type":"4"}},{"id":4216095,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":125886,"kind":"person","name":"Ravina Bernard","position":1,"cik":"0001711276","reported_name":"Ravina Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-06T20:38:59.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":5490,"price":10,"value":54900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":17157,"source":{"system":"sec-edgar","filing":"0001104659-17-055821","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465917055821/a4.xml","form_type":"4"}}]}